Lercanidipine is a calcium channel blocker, prescribed for hypertension.
Medication Safety Issues
Lercanidipine may be confused with lacidipine, levocarnitine
Not available in US
Storage and Stability
Store at room temperature. Store in original packaging to protect from moisture.
1% to 10%:
Cardiovascular: Flushing (3%), palpitations (≤2%), tachycardia (≤2%), peripheral edema (1%)
Central nervous system: Headache (4%), dizziness (1%)
Endocrine & metabolic: Increased gamma-glutamyl transferase (1%)
<1%, postmarketing, and/or case reports: Abdominal pain, allergic dermatitis, angina pectoris, anxiety, cardiac failure, chest pain, diaphoresis, diarrhea, drowsiness, dysgeusia, dyspepsia, dyspnea, fatigue, gastrointestinal disease, gingival hyperplasia, hypercholesterolemia, hypersensitivity, hypotension, impotence, increased serum transaminases (reversible), insomnia, leg cramps, malaise, migraine, myalgia, myocardial infarction, nausea, orthostatic hypotension, paresthesia, periorbital edema, polyuria, pruritus, skin rash, syncope, urinary frequency, urticaria, vertigo, vomiting, weakness